Background:Opioid Use disorders are emerging as a serious public health concern in India. Opioid substitution treatment is one of the emerging forms of treatment in this population which needs more evidence to increase its availability and address prejudices towards the same.Materials and Methods:This is a case control study with retrospective design reviewing the charts of patients with opioid dependence syndrome registered between January 2005 to December 2012. Adherence to treatment was the outcome variable assessed in this study.Results:The odds of the Buprenorphine Maintenance Treatment (BMT) group remaining in treatment is 4.5 (P < 0.005) times more than Naltrexone Maintenance Treatment (NMT) group and 7 times (P < 0.001) more than Psychosocial intervention (PST) alone group.Discussion:We believe that these study findings will help in reducing the prejudice towards BMT and encourage further research in this field.Conclusion:BMT has a better adherence rate than other treatments in opioid use disorders.
Background:Attention-deficit hyperactivity disorder (ADHD) and substance-use disorders often co-occur.Aim:Aim of this study was to look at the family loading of ADHD (in adults and children) in patients with alcohol-dependence syndrome (ADS) along with the estimation of morbidity risk (MR) for developing ADHD.Methods:Thirty-five male patients with ADS along with their 369 first-degree relatives (FDRs) – both children and adults – were recruited.Results:ADHD and residual ADD (ADDRT) were significantly more common in the early-onset (EO) ADS group and their FDR. In ADHD children, high MR (27.27%) for developing EO of ADS was noted.Discussion:Findings from this study raise an avenue for research in the Indian population about the shared risk between ADS and ADHD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.